272(top 1%)
papers
13.9K(top 1%)
citations
53(top 1%)
h-index
116(top 1%)
g-index
298
all documents
15.4K
doc citations
2.6K
citing journals
313
times ranked

Top Articles

#TitleJournalYearCitations
1CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell20091,371
2Personal Omics Profiling Reveals Dynamic Molecular and Medical PhenotypesCell20121,134
3Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaCell2010894
4Through-skull fluorescence imaging of the brain in a new near-infrared windowNature Photonics2014829
5CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cellsNature2016709
6Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47Science Translational Medicine2010591
7Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell2007485
8Oligodendrocyte precursors migrate along vasculature in the developing nervous systemScience2016319
9Controlling Epithelial Polarity: A Human Enteroid Model for Host-Pathogen InteractionsCell Reports2019316
10Fluorescence Imaging In Vivo at Wavelengths beyond 1500 nmAngewandte Chemie - International Edition2015310
11Resilience and Burnout Among Physicians and the General US Working PopulationJAMA Network Open2020257
12Dysregulated gene expression networks in human acute myelogenous leukemia stem cellsProceedings of the National Academy of Sciences of the United States of America2009253
13Engineered materials for organoid systemsNature Reviews Materials2019251
14The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPOCell2012244
15Impaired interferon signaling is a common immune defect in human cancerProceedings of the National Academy of Sciences of the United States of America2009240
16Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutationBlood2005233
17The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal TransplantationAmerican Journal of Transplantation2008224
18Thrombin Activatable Fibrinolysis Inhibitor, a Potential Regulator of Vascular InflammationJournal of Biological Chemistry2003193
19Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid MalignanciesFrontiers in Oncology2019187
20Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast CancerPLoS Medicine2005182
21γδ T Cells Recognize a Microbial Encoded B Cell Antigen to Initiate a Rapid Antigen-Specific Interleukin-17 ResponseImmunity2012172
22Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapyBlood2011159
23Precision identification of diverse bloodstream pathogens in the gut microbiomeNature Medicine2018158
24Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemiaBlood2020127
25Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetesNature Medicine2013125
26Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of MortalityJAMA Oncology2017125
27Down-Regulation of the Interferon Signaling Pathway in T Lymphocytes from Patients with Metastatic MelanomaPLoS Medicine2007124
28An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesisNature Communications2015121
29A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cellsMAbs2015117
30Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimensNature Medicine2009105
31Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of DiseaseCell Stem Cell2017101
32Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6ELife201794
33Age-associated changes in human hematopoietic stem cellsSeminars in Hematology201789
34Metrics for assessing physician activity using electronic health record log dataJournal of the American Medical Informatics Association: JAMIA202084
35The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes.Journal of Biological Chemistry199283
36Diversity and Recognition Efficiency of T Cell Responses to CancerPLoS Medicine200482
37Dynamics and Potential Impact of the Immune Response to Chronic Myelogenous LeukemiaPLoS Computational Biology200881
38The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy targetAnnals of Oncology201980
39Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic MastocytosisBiology of Blood and Marrow Transplantation201676
40Household triclosan and triclocarban effects on the infant and maternal microbiomeEMBO Molecular Medicine201776
41A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic TransformationCancer Discovery202175
42The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytesJournal of Biological Chemistry199271
43New Strategies in the Treatment of the ThalassemiasAnnual Review of Medicine200568
44Modeling regulation mechanisms in the immune systemJournal of Theoretical Biology200768
45STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infectionNature Communications201868
46High-throughput sequencing for noninvasive disease detection in hematologic malignanciesBlood201766
47CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interactionJournal of Biological Chemistry199266
48Physician Well-being 2.0: Where Are We and Where Are We Going?Mayo Clinic Proceedings202165
49Assessment of Electronic Health Record Use Between US and Non-US Health SystemsJAMA Internal Medicine202164
50What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse?Journal of Thrombosis and Haemostasis201061